Non-Invasive Monitoring of Potassium Levels in Patients with Congestive Heart Failure

Overview

About this study

The purpose of this study is to examine that signal processed ECGs can be used to monitor changes in serum concentrations of potassium based on T-wave features.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

New patients over age of 18
Establishing care at the Heart Failure Clinic at Mayo Clinic Rochester who are to be enrolled in the ACEI and spironolactone clinical up titration protocol for a diagnosis of congestive heart failure with reduced ejection fraction.
Are willing to comply with the study design and sign the informed consent

Exclusion Criteria:

Subjects with a history of an implantable pacemaker
Acute MI within the month prior to enrollment
Pregnant women

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Grace Lin, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Grace Lin, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials